Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
In this study we used stool profiling to identify intestinal bacteria and metabolites that are differentially represented in humans with colorectal cancer (CRC) compared to healthy controls to identify how microbial functions may influence CRC development. Stool samples were collected from healthy adults (n = 10) and colorectal cancer patients (n = 11) prior to colon resection surgery at the University of Colorado Health-Poudre Valley Hospital in Fort Collins, CO. The V4 region of the 16s rRNA gene was pyrosequenced and both short chain fatty acids and global stool metabolites were extracted and analyzed utilizing Gas Chromatography-Mass Spectrometry (GC-MS). There were no significant differences in the overall microbial community structure associated with the disease state, but several bacterial genera, particularly butyrate-producing species, were under-represented in the CRC samples, while a mucin-degrading species, Akkermansia muciniphila, was about 4-fold higher in CRC (p<0.01). Proportionately higher amounts of butyrate were seen in stool of healthy individuals while relative concentrations of acetate were higher in stools of CRC patients. GC-MS profiling revealed higher concentrations of amino acids in stool samples from CRC patients and higher poly and monounsaturated fatty acids and ursodeoxycholic acid, a conjugated bile acid in stool samples from healthy adults (p<0.01). Correlative analysis between the combined datasets revealed some potential relationships between stool metabolites and certain bacterial species. These associations could provide insight into microbial functions occurring in a cancer environment and will help direct future mechanistic studies. Using integrated "omics" approaches may prove a useful tool in identifying functional groups of gastrointestinal bacteria and their associated metabolites as novel therapeutic and chemopreventive targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“a few cross-sectional studies reported that patients with CRC had a lower abundance of butyrate-producing species and lower fecal levels of butyrate than controls (Table 1).97, 133–135”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [97]
In the citing paper
“Nevertheless, A. muciniphila has previously been linked to an increased burden of CRC in human and mice,25–27”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“A healthy gastrointestinal system relies on a balanced commensal biota to regulate processes such as dietary energy harvest [1], metabolism of microbial and host derived chemicals [2], and immune modulation [3].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 2×
“Prevotella was a dominant genera reported in stool from children in a rural community in Burkina Faso but absent from a cohort of Italian children, and the study authors hypothesized that Prevotella helped maximize energy harvest from a plant-based diet [29].”
BackgroundSmith, C. A., Want, E. J., O'Maille, G., Abagyan, R., & Siuzdak, G. (2006) · Analytical Chemistry · doi:10.1021/ac051437y · Cited by 5,262
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Nicholson, J. K., & Lindon, J. C. (2008) · Nature · doi:10.1038/4551054a · Cited by 1,886
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Png, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., McGuckin, M. A., & Florin, T. H. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.281 · Cited by 1,364 · cited 2×
“This bacterium is a common member of the colonic microbiota and was recently shown to be reduced in irritable bowel syndrome and Crohn’s Disease [32]; however a more recent report showed increased A. muciniphila in ulcerative colitis-associated pouchitis [33].”
Background
Research works printed but not linked: 1
- J Byrd, 2004, Mucins and mucin binding proteins in colorectal cancer, Cancer and Metastasis Reviews, 23, 77, 10.1023/A:1025815113599 · DOI · Paper page
Cited by
Items 201–300 of 642
Daniel, S. G., Ball, C. L., Besselsen, D. G., Doetschman, T., & Hurwitz, B. L. (2017) · mSystems · doi:10.1128/msystems.00065-17 · Cited by 58
Review of short-chain fatty acids effects on the immune system and cancer
Fattahi, Y., Heidari, H. R., & Khosroushahi, A. Y. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100793 · Cited by 64
Lin, Y., Ma, C., Bezabeh, T., Wang, Z., Liang, J., Huang, Y., Zhao, J., Liu, X., Ye, W., Tang, W., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32190 · Cited by 57
Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences
Tortora, S. C., Bodiwala, V., Quinn, A., Martello, L. A., & Vignesh, S. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i2.375 · Cited by 66
Chapkin, R. S., Navarro, S. L., Hullar, M. A. J., & Lampe, J. W. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06106-8 · Cited by 60
Sze, M. A., & Schloss, P. D. (2018) · mBio · doi:10.1128/mbio.00630-18 · Cited by 55
“Other sequence and metadata were obtained directly from the authors (n 4 [17, 23, 25, 27]).”
Zhou, J., Tang, L., Wang, J., & Wang, J. G. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy102 · Cited by 65
Ring, C., Klopfleisch, R., Dahlke, K., Basic, M., Bleich, A., & Blaut, M. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1511663 · Cited by 52
“muciniphila compared with healthy controls.(19) These inconsistent effects of A.”
BackgroundMicrobial Metabolite Dysbiosis and Colorectal Cancer
Niekamp, P., & Kim, C. H. (2023) · Gut and Liver · doi:10.5009/gnl220260 · Cited by 64
“Interestingly, it has been observed that CRC patients had lower stool concentrations of butyrate, while acetate concentrations were increased.(48,50) In a gnotobiotic mouse model colonized with either wild-type or mutant strains of the butyrate-producing bacterium Butyrivibrio fibrisolvens, high levels of dietary fibe…”
BackgroundRojo, D., Gosalbes, M. J., Ferrari, R. G., Pérez‐Cobas, A. E., Hernández, E., Oltra, R., Buesa, J., Latorre, A., Barbas, C., Ferrer, M., et al. (2015) · The ISME Journal · doi:10.1038/ismej.2015.32 · Cited by 58
“, 2008); and (iv) 22 metabolites allow the discrimination of patients with colorectal cancer from healthy adults (Weir et al., 2013).”
BackgroundInfluentialGoedert, J. J., Gong, Y., Hua, X., Zhong, H., He, Y., Peng, P., Yu, G., Wang, W., Ravel, J., Shi, J., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.04.010 · Cited by 59
“Comprehensive comparisons of the fecal microbiota have been reported by four studies, totaling 176 CRC cases and 241 controls (Ahn et al., 2013; Wang et al., 2012; Weir et al., 2013; Wu et al., 2013; Zeller et al., 2014).”
Sanchez, S. D., Perrotta, A. R., Rockafellow, I., Alm, E. J., Okimoto, R., Hawken, R., & Hanning, I. B. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216080 · Cited by 64
“It has been suggested that these reads are derived from off-target amplification of food related plant material and are often removed prior to downstream analysis [26,27,28].”
BackgroundMASI: microbiota—active substance interactions database
Zeng, X. L., Yang, X., Fan, J., Tan, Y. C., Ju, L., Shen, W. X., Wang, Y., Wang, X., Chen, W., Ju, D., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa924 · Cited by 54
“For instance, BPA exposure has led to increased Prevotellaceae in the gut microbiome of male mice, which may affect the mucosal barrier function (38), BPA exposure has also led to upregulated Akkermansia and Methanobrevibacter in the gut microbiome of males, which is of concern of cancer risks because Akkermansia is i…”
BackgroundMicrobe–Mucus Interface in the Pathogenesis of Colorectal Cancer
Coleman, O. I., & Haller, D. (2021) · Cancers · doi:10.3390/cancers13040616 · Cited by 57
“muciniphila in CRC patients, which may be a consequence of the overexpression of certain types of mucins in CRC [93,94].”
BackgroundPfalzer, A. C., Nesbeth, P.-D. C., Parnell, L. D., Iyer, L. K., Liu, Z., Kane, A. V., Chen, C. O., Tai, A., Bowman, T. A., Obin, M. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135758 · Cited by 59
“Weir et al profiled the fecal metabolome of human subjects with and without CRC and identified 22 biochemicals with differing abundances [50].”
BackgroundRezasoltani, S., Sharafkhah, M., Aghdaei, H. A., Mojarad, E. N., Dabiri, H., Sepahi, A. A., Modarressi, M. H., Feizabadi, M. M., & Zali, M. R. (2018) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2018.11.007 · Cited by 56
Comparative genomic and functional analysis of Akkermansia muciniphila and closely related species
Xing, J., Li, X., Sun, Y., Zhao, J., Miao, S., Xiong, Q., Zhang, Y., & Zhang, G. (2019) · Genes & Genomics · doi:10.1007/s13258-019-00855-1 · Cited by 53
The Emerging Biotherapeutic Agent: Akkermansia
Kalia, V. C., Gong, C., Shanmugam, R., Lin, H. M., Zhang, L., & Lee, J.-K. (2021) · Indian Journal of Microbiology · doi:10.1007/s12088-021-00993-9 · Cited by 57
Gut microbiota short-chain fatty acids and their impact on the host thyroid function and diseases
Mendoza-León, M. J., Mangalam, A. K., Regaldiz, A., González-Madrid, E., Rangel-Ramírez, M. A., Álvarez-Mardones, O., Vallejos, O. P., Méndez, C., Bueno, S. M., Melo-González, F., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1192216 · Cited by 63
Gut Microbial Glycerol Metabolism as an Endogenous Acrolein Source
Zhang, J., Sturla, S. J., Lacroix, C., & Schwab, C. (2018) · mBio · doi:10.1128/mbio.01947-17 · Cited by 56
“Thus, glycerol has been observed in human feces (25).”
BackgroundMicrobial Metabolites in Colorectal Cancer: Basic and Clinical Implications
Peng, Y., Nie, Y., Yu, J., & Wong, C. C. (2021) · Metabolites · doi:10.3390/metabo11030159 · Cited by 56
Faghfuri, E., & Gholizadeh, P. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116416 · Cited by 57
Effects of Walnut Consumption on Colon Carcinogenesis and Microbial Community Structure
Nakanishi, M., Chen, Y., Qendro, V., Miyamoto, S., Weinstock, E., Weinstock, G. M., & Rosenberg, D. W. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0026 · Cited by 55
“In fact, members of this genus have also been found at higher concentrations in patients with colorectal cancer (47) and inmice harboring AOM/DSS-induced colon tumors (48).”
BackgroundZhang, S., Yang, J., Henning, S. M., Lee, R., Hsu, M., Grojean, E. M., Pisegna, R., Ly, A., Heber, D., & Li, Z. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.08.017 · Cited by 55
Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms
Amitay, E. L., Krilavičiūtė, A., & Brenner, H. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1445957 · Cited by 67
Metabolomics and the Multi-Omics View of Cancer
Wishart, D. S. (2022) · Metabolites · doi:10.3390/metabo12020154 · Cited by 58
Park, H., Cho, D., Huang, E., Seo, J. Y., Kim, W. G., Todorov, S. D., Ji, Y., & Holzapfel, W. H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00420 · Cited by 54
Colorectal Cancer and Probiotics: Are Bugs Really Drugs?
Lamichhane, P., Maiolini, M., Alnafoosi, O., Hussein, S., Alnafoosi, H., Umbela, S., Richardson, T., Alla, N., Lamichhane, N., Subhadra, B., et al. (2020) · Cancers · doi:10.3390/cancers12051162 · Cited by 50
Ramaboli, M. C., Ocvirk, S., Mirzaei, M. K., Eberhart, B. L., Valdivia‐Garcia, M., Metwaly, A., Neuhaus, K., Barker, G. F., Ru, J., Nesengani, L. T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46265-0 · Cited by 65
Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review
Han, S., Gao, J., Zhou, Q., Liu, S., Wen, C., & Xi, Y. (2018) · Cancer Management and Research · doi:10.2147/cmar.s153482 · Cited by 55
“Third, various metabolic products of the intestinal flora can, directly or indirectly, promote development and progression of colorectal cancer.(60) Fourth, micro-ecology helps to prevent tumorigenesis by reestablishing the intestinal micro-ecological balance.”
BackgroundNavarro, S. L., Neuhouser, M. L., Cheng, T. D., Tinker, L. F., Shikany, J. M., Snetselaar, L., Martinez, J. A., Kato, I., Beresford, S. A. A., Chapkin, R. S., et al. (2016) · Nutrients · doi:10.3390/nu8120779 · Cited by 54
“, pectins, a type of fermentable soluble fiber) to butyrate [36–49], a potent histone deacetylase (HDAC) inhibitor [29,30] associated with reduced CRC risk [50–52].”
BackgroundQiu, Y., Chen, X., Yan, X., Wang, J., Yu, G., Ma, W., Xiao, B., Quinones, S., Tian, X., & Ren, X. (2020) · Environment International · doi:10.1016/j.envint.2020.105763 · Cited by 48
Fang, C., Chen, J., Hsu, B., Hussain, B., Rathod, J., & Lee, K. (2021) · Microorganisms · doi:10.3390/microorganisms9081548 · Cited by 51
“Previous studies have revealed that the intestinal mucosa and fecal flora are different in patients with colorectal cancer [15,22].”
BackgroundTingler, A. M., & Engevik, M. A. (2025) · Infection and Immunity · doi:10.1128/iai.00503-24 · Cited by 68
“Consistent with these results, Weir et al . uncovered that A. muciniphila is four times more frequent in colorectal cancer patients versus healthy adults (297).”
The Role of the Gut Microbiome in Colorectal Cancer
Chen, G. (2018) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0037-1602239 · Cited by 56
Fundamentals of Ion Mobility-Mass Spectrometry for the Analysis of Biomolecules
Morris, C. B., Poland, J. C., May, J. C., & MCLEAN, J. A. J. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0030-6_1 · Cited by 57
Foes or Friends? Bacteria Enriched in the Tumor Microenvironment of Colorectal Cancer
Xu, S., Yin, W., Zhang, Y., Lv, Q., Yang, Y., & He, J. (2020) · Cancers · doi:10.3390/cancers12020372 · Cited by 52
“For example, Fusobacterium nucleatum can activate the Wnt/β-catenin pathway, stimulate cancer cell growth, and promote CRC development [26]; however, Akkermansia muciniphila can instead enhance the efficacy of programmed death 1 (PD-1) based immunotherapy against CRC [27].”
BackgroundResultInfluentialXu, J., Li, M., Zhang, Y., Chu, S., Huo, Y., Zhao, J., & Wan, C. C. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000353 · Cited by 50
Zidi, O., Souai, N., Raies, H., Ayed, F. B., Mézlini, A., Mezrioui, S., Tranchida, F., Sabatier, J., Mosbah, A., Cherif, A., et al. (2021) · Molecules · doi:10.3390/molecules26082266 · Cited by 52
“Several previous metabolomic studies have proposed the use of gut microbiota metabolites in disease diagnosis, revealing key biomarkers in colorectal cancer [23,24], diabetes [25], and gastrointestinal disorders.”
BackgroundBacterial outer membrane vesicles in cancer: Biogenesis, pathogenesis, and clinical application
Li, D., Zhu, L., Wang, Y., Zhou, X., & Li, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115120 · Cited by 51
dos Reis, S. A., da Conceição, L. L., & Pelúzio, M. D. C. G. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001049 · Cited by 48
Impact of air quality on the gastrointestinal microbiome: A review
Dujardin, C. E., Mars, R. A. T., Manemann, S. M., Kashyap, P., Clements, N. S., Hassett, L. C., & Roger, V. L. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109485 · Cited by 47
Lu, S., Wang, C., Ma, J., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1456030 · Cited by 56
Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine
Contreras, A. V., Cocom-Chan, B., Hernández‐Montes, G., Portillo-Bobadilla, T., & Reséndis-Antonio, O. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00606 · Cited by 52
Gheorghe, A. S., Negru, S. M., Preda, M., Mihăilă, R. I., Komporaly, I. A., Dumitrescu, E. A., Lungulescu, C. V., Kajanto, L. A., Georgescu, B., Radu, E. A., et al. (2022) · Nutrients · doi:10.3390/nu14061152 · Cited by 50
“In CRC samples, significantly higher relative concentrations of isobutyric and isovaleric acid were observed as well, being products from the bacterial metabolism of branched-chain amino acids valine and leucine, also higher in CRC stool samples [22].”
BackgroundResultInfluentialGut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer
Gou, H., Zeng, R., Lau, H. C.-H., & Yu, J. Q. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107373 · Cited by 51
The Pivotal Role of the Gut Microbiome in Colorectal Cancer
Siddiqui, R., Boghossian, A., Alharbi, A. M., Alfahemi, H. H., & Khan, N. A. (2022) · Biology · doi:10.3390/biology11111642 · Cited by 47
“Of these three SCFAs, butyrate is the most studied, and that is due to its anti-tumor nature [47].”
BackgroundFecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer
Song, E. M., Byeon, J., Lee, S., Yoo, H. J., Kim, S. J., Lee, S.-H., Chang, K., Hwang, S. W., Yang, D., & Jeong, J. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-4982-y · Cited by 48
Iadsee, N., Chuaypen, N., Techawiwattanaboon, T., Jinato, T., Patcharatrakul, T., Malakorn, S., Petchlorlian, A., Praditpornsilpa, K., & Patarakul, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-33794-9 · Cited by 51
Breath volatile organic compound analysis: an emerging method for gastric cancer detection
Zhang, J., Tian, Y., Luo, Z., Qian, C., Li, W., & Duan, Y. (2021) · Journal of Breath Research · doi:10.1088/1752-7163/ac2cde · Cited by 43
“The concentration changes of SCFAs detected in fecal metabolites have been considered to be related to inflammatory bowel diseases and colorectal cancer [141, 142].”
Dey, P., & Chaudhuri, S. R. (2022) · Biology · doi:10.3390/biology11050757 · Cited by 46
Jenkins, S. V., Robeson, M. S., Griffin, R. J., Quick, C. M., Siegel, E. R., Cannon, M. J., Vang, K. B., & Dings, R. P. M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-4108 · Cited by 41
“An important next step will be defining the commensal bacterial species, or mixture, and the metabolome responsible for maintaining a more competent immunogenic tumor microenvironment (39, 49, 50).”
Backgroundvan Liere, E. L. S. A., van Dijk, L. J., Bosch, S., Vermeulen, L., Heymans, M. W., Burchell, G. L., de Meij, T. G. J., Ramsoekh, D., & de Boer, N. K. H. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.03.002 · Cited by 45
Wang, M., Wang, Z., Lessing, D. J., Guo, M., & Chu, W. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02292-23 · Cited by 46
Herstad, K. M. V., Moen, A. E. F., Gaby, J. C., Moe, L., & Skancke, E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198342 · Cited by 47
Growth rate alterations of human colorectal cancer cells by 157 gut bacteria
Taddese, R., Garza, D. R., Ruiter, L. N., de Jonge, M. I., Belzer, C., Aalvink, S., Nagtegaal, I. D., Dutilh, B. E., & Boleij, A. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1799733 · Cited by 47
Kashyap, S., Pal, S., Chandan, G., Saini, V., Chakrabarti, S., Saini, N. K., Mittal, A., Thakur, V. K., Saini, A. K., & Saini, R. V. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.020 · Cited by 45
Bacterial Extracellular Vesicles in Gastrointestinal Tract Cancer: An Unexplored Territory
Amatya, S. B., Salmi, S., Kainulainen, V., Karihtala, P., & Reunanen, J. (2021) · Cancers · doi:10.3390/cancers13215450 · Cited by 45
Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?
Tarashi, S., Siadat, S. D., Badi, S. A., Zali, M. R., Biassoni, R., Ponzoni, M., & Moshiri, A. (2019) · Microorganisms · doi:10.3390/microorganisms7110561 · Cited by 40
“Bacteriodes Kostic [124] 2012 Spain T CRC WGS Zackular [125] 2014 Michigan S CRC/CRA 16S rDNA Sequencing Wang [99] 2012 China S CRC 16S rDNA Sequencing Weir [85] 2013 USA S CRC 16S rDNA Sequencing Allali [36] 2018 Morocco S CRC 16S rDNA Sequencing Shen [114] 2010 USA T CRA 16S rDNA Sequencing Nakatsu [27] 2015 2011–20…”
BackgroundMethodInfluentialInfluence of Iron on the Gut Microbiota in Colorectal Cancer
Phipps, O., Al-Hassi, H. O., Quraishi, M. N., Kumar, A., & Brookes, M. (2020) · Nutrients · doi:10.3390/nu12092512 · Cited by 44
“On the other hand, beneficial strains of bacteria such as butyrate-producing species have been shown to be under-represented in colorectal cancers, which is consistent with a reduced amount butyrate being seen in the stool of colorectal cancer patients compared to normal individuals [41].”
BackgroundFecal volatile organic compounds for early detection of colorectal cancer: where are we now?
Bosch, S., Berkhout, D. J. C., Larbi, I. B., de Meij, T. G. J., & de Boer, N. K. H. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2821-3 · Cited by 44
Strain, C., Collins, K. C., Naughton, V. R., McSorley, E. M., Stanton, C., Smyth, T. J., Soler‐Vila, A., Rea, M. C., Ross, R. P., Cherry, P., et al. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-01909-6 · Cited by 49
Gut microbial metabolites in cancer therapy
Song, P., Peng, Z., & Guo, X. (2025) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.06.016 · Cited by 38
Russo, E., Gloria, L. D., Nannini, G., Meoni, G., Niccolai, E., Ringressi, M. N., Baldi, S., Fani, R., Tenori, L., Taddei, A., et al. (2023) · Neoplasia · doi:10.1016/j.neo.2023.100901 · Cited by 47
Microbiome metabolite quantification methods enabling insights into human health and disease
Laro, J. A., Mital, R., Haffner, J. J., Colwell, N., Coats, R., Palacios, H. M., Liu, Z., Godinho, J. L. P., Ness, M., Peramuna, T., et al. (2024) · Methods · doi:10.1016/j.ymeth.2023.12.007 · Cited by 43
From Genotype to Functional Phenotype: Unraveling the Metabolomic Features of Colorectal Cancer
Bathe, O. F., & Farshidfar, F. (2014) · Genes · doi:10.3390/genes5030536 · Cited by 43
“gut microbiome [89].”
Howe, C. S., Kim, S. J., Mitchell, J., Im, E., Kim, Y. S., Kim, Y. S., & Rhee, S. H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.006 · Cited by 41
“The abundance of Akkermansia muciniphila has been measured to be 4 times higher in the stool samples of CRC patients than healthy subjects[47]; moreover, Akkermansia muciniphila colonization exacerbates tumor development in the intestine of Apc min/+ mice [46].”
BackgroundMessaritakis, I., Vogiatzoglou, K., Tsantaki, K., Ntretaki, A., Sfakianaki, M., Koulouridi, A., Tsiaoussis, J., Mavroudis, D., & Souglakos, J. (2020) · Cancers · doi:10.3390/cancers12041058 · Cited by 41
Tveter, K. M., Villa-Rodríguez, J. A., Cabales, A., Zhang, L., Bawagan, F. G., Duran, R. M., & Roopchand, D. E. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001386 · Cited by 42
Debesa-Tur, G., Pérez‐Brocal, V., Ruiz‐Ruiz, S., Castillejo, A., Latorre, A., Soto, J. L., & Moyá, A. (2021) · Scientific Reports · doi:10.1038/s41598-020-79874-y · Cited by 44
The gut microbiome in patients with chronic lymphocytic leukemia
Faitová, T., Svanberg, R., da Cunha‐Bang, C., Ilett, E. E., Jørgensen, M., Noguera-Julián, M., Paredes, R., MacPherson, C. R., & Niemann, C. U. (2022) · Haematologica · doi:10.3324/haematol.2021.280455 · Cited by 36
Tewari, N., & Dey, P. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127832 · Cited by 44
Metabolite quantification of faecal extracts from colorectal cancer patients and healthy controls
Gall, G. L., Guttula, K., Kellingray, L., Tett, A., ten Hoopen, R., Kemsley, E. K., Savva, G. M., Ibrahim, A. E. K., & Narbad, A. (2018) · Oncotarget · doi:10.18632/oncotarget.26022 · Cited by 42
“Similarly, conflicting results emerged on acetate with three studies reporting an increase in concentration [16, 18, 20] while two others stated a decrease [14, 19].”
Mass spectrometry-based fecal metabolome analysis
Xu, J., Zhang, Q., Zheng, J., Yuan, B., & Feng, Y. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.12.027 · Cited by 42
Güven, D. C., Dızdar, Ö., Alp, A., Kıttana, F. N. A., Karakoç, D., Hamaloğlu, E., Laçin, Ş., Karakaş, Y., Kılıçkap, S., Hayran, M., et al. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0020 · Cited by 42
Luo, J., Li, T., Xie, J., Guo, H., Liu, L., Zhang, G., & Peng, X. (2020) · Food & Function · doi:10.1039/c9fo02786f · Cited by 40
Characterization of the fecal microbiota in gastrointestinal cancer patients and healthy people
Li, N., Bai, C., 管远志, Zhao, L., Ge, Y., & Li, X. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02754-y · Cited by 40
“muciniphila were also found to be more abundant in the feces of patients with colorectal cancer [40, 41].”
BackgroundHost–MicroRNA–Microbiota Interactions in Colorectal Cancer
Yuan, C., Steer, C. J., & Subramanian, S. (2019) · Genes · doi:10.3390/genes10040270 · Cited by 43
“In stool samples from patients with CRC, a higher level of amino acids and a lower level of fatty acids have also been observed [108].”
BackgroundJaworska, K., Konop, M., Maksymiuk, K. M., Hutsch, T., Dziekiewicz, M., Banaszkiewicz, A., & Ufnal, M. (2019) · Experimental Physiology · doi:10.1113/ep087773 · Cited by 44
“…their metabolic activity, which is affected by numerous interindividual differences, such as diet and demographic factors (Bourriaud et al., 2005; Weir et al., 2013), the proposed GBB permeability assessment is based on the measurement of portal blood (rats), systemic blood (rats and humans) and…”
A simplified method for the quantitation of short-chain fatty acids in human stool
Eberhart, B. L., Wilson, A. S., O’Keefe, S. J., Ramaboli, M. C., & Nesengani, L. T. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.114016 · Cited by 40
Erben, V., Poschet, G., Schrotz‐King, P., & Brenner, H. (2021) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2020-000202 · Cited by 52
Metabolic modeling with Big Data and the gut microbiome
Sung, J., Hale, V., Merkel, A. C., Kim, P.-J., & Chia, N. (2016) · Applied & Translational Genomics · doi:10.1016/j.atg.2016.02.001 · Cited by 35
“Other examples of omic data integration include the combination of microbiome and metabolome data in the study of colon cancer (Weir et al., 2013), proteome and metagenome data related to Crohn's disease (Erickson et al., 2012), and metabolome, metagenome, and metatranscriptome data to examine the…”
BackgroundGut microbiota and artificial intelligence approaches: A scoping review
Iadanza, E., Fabbri, R., Bašić-Čičak, D., Amedei, A., & Telalović, J. H. (2020) · Health and Technology · doi:10.1007/s12553-020-00486-7 · Cited by 44
Microbial dysbiosis and epigenetics modulation in cancer development – A chemopreventive approach
Haque, S., Raina, R., Afroze, N., Hussain, A., Alsulimani, A., Singh, V., Mishra, B. N., Kaul, S., & Kharwar, R. N. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.024 · Cited by 38
The Application of High-Throughput Technologies for the Study of Microbiome and Cancer
Wei, L., Cheong, I. H., Yang, G., Li, X. G., Kozlakidis, Z., Ding, L., Liu, N. N., & Wang, H. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.699793 · Cited by 45
Ward, M. A., Pierre, J. F., Leal, R. F., Huang, Y., Shogan, B. D., Dalal, S. R., Weber, C. R., Leone, V., Musch, M. W., An, G. C., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00017.2016 · Cited by 36
“1D) is almost certainly a consequence of intestinal stasis, a condition shared between normal murine colon and murine blind SFL, and is similar to the microbiome profile of healthy humans (23).”
ResultDovrolis, N., Kolios, G. C., Spyrou, G. M., & Maroulakou, I. G. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx154 · Cited by 39
Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites
Han, S., Jing, Z., Wu, Y., Wu, W., & Yang, X. (2020) · Cancer Management and Research · doi:10.2147/cmar.s268943 · Cited by 40
Masheghati, F., Asgharzadeh, M. R., Jafari, A., Masoudi, N., & Maleki, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122529 · Cited by 39
Lee, J. H. J., & Zhu, J. (2020) · Metabolites · doi:10.3390/metabo10090351 · Cited by 32
“and Pseudobutyrivibrio ruminis, produced butyrate [44,45].”
Chen, L., Sun, X., Khalsa, A. S., Bailey, M. T., Kelleher, K. J., Spees, C., & Zhu, J. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114066 · Cited by 31
The role played by bacterial infections in the onset and metastasis of cancer
Khatun, S., Appidi, T., & Rengan, A. K. (2021) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2021.100078 · Cited by 48
van Vorstenbosch, R., Cheng, H. R., Jonkers, D. M. A. E., Penders, J., Schoon, E. J., Masclee, A., van Schooten, F., Smolinska, A., & Mujagic, Z. (2022) · Metabolites · doi:10.3390/metabo13010055 · Cited by 35
“Seven studies also included data on fecal microbiota composition and/or activity [33,36,52,68,87,89,90,92] and one study on tissue [68].”
BackgroundInfluentialShah, M. S., DeSantis, T. Z., Yamal, J., Weir, T. L., Ryan, E. P., Cope, J. L., & Hollister, E. B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207002 · Cited by 35
Pan, H., Du, L., Li, W., Yang, Y., Zhang, Y., & Wang, C. (2020) · Research in Microbiology · doi:10.1016/j.resmic.2020.01.001 · Cited by 34
Casimiro‐Soriguer, C. S., Loucera, C., Peña-Chilet, M., & Dopazo, J. (2022) · Scientific Reports · doi:10.1038/s41598-021-04182-y · Cited by 44
“It has been described that cancer cells undergo modi�cations that include increased glutamine catabolism and over-expression of enzymes involved in glutaminolysis, including glutaminase 70 , which is liberated to the gut 71 and promotes the proliferation of bacteria containing this bacterial module.”
BackgroundComparison of extraction methods for intracellular metabolomics of human tissues
Andresen, C., Boch, T., Gegner, H. M., Mechtel, N., Narr, A., Birgin, E., Rasbach, E., Rahbari, N. N., Trumpp, A., Poschet, G., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.932261 · Cited by 34
“We developed or adapted these protocols based on our own preliminary experience and literature review (Lisec et al., 2006; Rabinowitz and Kimball, 2007; Ivanisevic et al., 2013; Weir et al., 2013; Lee et al., 2014; Zukunft et al., 2018) or the Biocrates SOP for processing of cell pellets for analyses via AbsoluteIDQ p…”
MethodTowards Standards for Human Fecal Sample Preparation in Targeted and Untargeted LC-HRMS Studies
Hosseinkhani, F., Dubbelman, A.-C., Karu, N., Harms, A. C., & Hankemeier, T. (2021) · Metabolites · doi:10.3390/metabo11060364 · Cited by 34
“For example, elevated concentrations of amino acids, saturated fatty acids, and ursodeoxycholic acid were reported in fecal samples of colorectal cancer patients [5], whereas increased levels of deoxycholic acid, L-tryptophan and putrescine were found in fecal samples of patients with systemic lupus erythematosus [6].”
BackgroundLuo, Y., Lan, C., Xie, K., Li, H., Devillard, E., He, J., Liu, L., Cai, J., Tian, G., Wu, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.788638 · Cited by 37
Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer
Camp, E. R., Patterson, L., KESTER, M. A., & Voelkel‐Johnson, C. (2017) · Cancer Biology & Therapy · doi:10.1080/15384047.2017.1345396 · Cited by 37
“to increased tumorigenesis.(34,35) While sphingolipids have been”
Metadata
- Authors
- Weir, T. L., Manter, D. K., Sheflin, A. M., Barnett, B. A., Heuberger, A. L., & Ryan, E. P.
- Affiliations
- Colorado State University (US)
- Agricultural Research Service (US)
- Corresponding author
- Weir, Tiffany L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-08-06
- Volume
- 8
- Issue
- 8
- Pages
- e70803
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3735522
- OpenAlex
- W2115450300
- Cited by
- 642
- References
- 48
- Citations by year
- 2026: 15 · 2025: 40 · 2024: 37 · 2023: 60 · 2022: 66 · 2021: 67 · 2020: 67 · 2019: 74 · 2018: 58 · 2017: 53 · 2016: 54 · 2015: 29 · 2014: 21 · 2013: 1
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Cancer Institute (R03CA150070)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- colorectal cancer, gut microbiota, Akkermansia muciniphila, butyrate, short-chain fatty acids, mucin degradation, ursodeoxycholic acid, bile acids, amino acids, polyunsaturated fatty acids, monounsaturated fatty acids, acetate, 16S rRNA gene, chemoprevention
- MeSH terms
- Adult, Aged, Aged, 80 and over, Carcinoma in Situ, Feces, Female, Health, Humans, Male, Middle Aged, Colorectal Neoplasms, Case-Control Studies, Metabolome, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.